Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Sequential Embryo Transfer Compared to Blastocyst Embryo Transfer in in Vitro Fertilization (Ivf) Cycle in Patients With the Three Repeated Consecutive Ivf. a Randomized Controlled Trial Publisher Pubmed



Tehraninejad ES1 ; Raisi E1 ; Ghaleh FB1 ; Rashidi BH1 ; Aziminekoo E2 ; Kalantari V3 ; Haghollahi F1 ; Shariat M4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Vali –Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Jacobi Medical Center, Albert Enstein University, Bronx, NY, United States
  3. 3. American University of Integrated Medicine, St. Maarten School of Medicine Office, Cole Bay, Saint Martin (Dutch Part)
  4. 4. Maternal, Fetal & Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Gynecological Endocrinology Published:2019


Abstract

The purpose of this study was to determine the pregnancy rate in the double sequential transfer of embryos on both day 3 and day 5 compared to day 5 alone, in in vitro fertilization-embryo transfer (IVF/ET) in patients with the three repeated consecutive IVF failures. In this controlled trial, women scheduled for IVF/ET with the three repeated consecutive IVF failures were randomized to either sequential transfer of embryos on day 2 and on day 5 after ovum pick-up (group 1, n = 60) or blastocyst ET on day 5 (group 2, n = 60) as a control group. The primary outcome measures were the chemical and clinical pregnancy rate. Baseline and cycle characteristics were comparable in both groups. Chemical and clinical pregnancy rate was similar in the sequential ET group (40%) compared to the day 5 of ET group (38.3%) (p value =.85). It seems that the double ET does not increase the chance of pregnancy rate compared to blastocyst ET on day 5 in the patients with the three repeated IVF-ET failures. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.